
|Articles|September 28, 2012
How to Reach First-in-Man Studies Successfully
Author(s)Angie Drakulich
What’s the best way to reach first-in-man studies when you have little to no information? Bioavailability issues, financial constraints.
Advertisement
What’s the best way to reach first-in-man studies when you have little to no information? Bioavailability issues, financial constraints, and pressure to meet accelerated deadlines can affect development, so having a firm plan in place is key. PharmTech is hosting a free educational
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Chooses 7 Companies for PreCheck Pilot
2
Roche Gets Priority Review for Enspryng; Announces Sequencing Platform
3
Manufacturing Deficiencies Behind FDA's Oxylanthanum Carbonate Rejection
4
PharmTech Weekly Roundup—June 26, 2026
5

